title: Deal watch: XOMA and Servier to develop anti-IL-1β antibody for inflammatory diseases.
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001528:Behcet Syndrome / Q000188:drug therapy; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D053583:Interleukin-1beta / Q000037:antagonists & inhibitors / Q000276:immunology*; D009965:Orphan Drug Production; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D053583:Interleukin-1beta